ETR Stock Overview
Etropal AD engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Etropal AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв4.40 |
| 52 Week High | лв5.80 |
| 52 Week Low | лв4.00 |
| Beta | 0.13 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -24.14% |
| 3 Year Change | -22.12% |
| 5 Year Change | -16.19% |
| Change since IPO | -26.67% |
Recent News & Updates
Recent updates
We Think Etropal AD (BUL:ETR) Can Stay On Top Of Its Debt
Apr 13
Etropal AD (BUL:ETR) Is Making Moderate Use Of Debt
Mar 24Etropal AD (BUL:ETR) Use Of Debt Could Be Considered Risky
May 11We Think Etropal AD (BUL:5EO) Is Taking Some Risk With Its Debt
Jan 26
Should Weakness in Etropal AD's (BUL:5EO) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Dec 04Shareholder Returns
| ETR | BG Medical Equipment | BG Market | |
|---|---|---|---|
| 7D | -2.2% | -0.2% | 0.5% |
| 1Y | -24.1% | -6.2% | 16.9% |
Return vs Industry: ETR underperformed the BG Medical Equipment industry which returned 2.1% over the past year.
Return vs Market: ETR underperformed the BG Market which returned 16.1% over the past year.
Price Volatility
| ETR volatility | |
|---|---|
| ETR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in BG Market | 8.4% |
| 10% least volatile stocks in BG Market | 2.3% |
Stable Share Price: ETR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ETR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 96 | Lyubomir Kolchev | www.etropal.eu |
Etropal AD engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria. The company offers capillary dialyzers; arterial-venous(A/V) blood line sets; procedure kits; and A/V fistula needles. The company was founded in 1976 and is headquartered in Etropole, Bulgaria.
Etropal AD Fundamentals Summary
| ETR fundamental statistics | |
|---|---|
| Market cap | лв22.00m |
| Earnings (TTM) | лв32.00k |
| Revenue (TTM) | лв11.18m |
687.5x
P/E Ratio2.0x
P/S RatioIs ETR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ETR income statement (TTM) | |
|---|---|
| Revenue | лв11.18m |
| Cost of Revenue | лв7.16m |
| Gross Profit | лв4.02m |
| Other Expenses | лв3.99m |
| Earnings | лв32.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0064 |
| Gross Margin | 35.96% |
| Net Profit Margin | 0.29% |
| Debt/Equity Ratio | 59.2% |
How did ETR perform over the long term?
See historical performance and comparison